Cambridge Cognition (LON:COG) Stock Passes Above 50 Day Moving Average of $127.54

Cambridge Cognition Holdings Plc (LON:COGGet Rating) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 127.54 ($1.54) and traded as high as GBX 144 ($1.74). Cambridge Cognition shares last traded at GBX 128 ($1.55), with a volume of 51,430 shares.

Cambridge Cognition Trading Down 7.2 %

The company has a 50-day moving average price of GBX 127.54 and a 200-day moving average price of GBX 133.92. The firm has a market capitalization of £39.90 million and a price-to-earnings ratio of 12,800.00. The company has a debt-to-equity ratio of 2.85, a quick ratio of 0.87 and a current ratio of 1.01.

Insider Activity at Cambridge Cognition

In other news, insider Matthew Stork bought 22,950 shares of the firm’s stock in a transaction that occurred on Thursday, July 21st. The stock was purchased at an average cost of GBX 113 ($1.37) per share, with a total value of £25,933.50 ($31,335.79).

About Cambridge Cognition

(Get Rating)

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases I-IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication.

See Also

Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with's FREE daily email newsletter.